Delivery Order HT940622D0002-HT941023F0004
- Not listed
- This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The $833,285.36 firm fixed-price purchase order has a performance period ending on June 22, 2023. RLS (USA) Inc. is a small business that specializes in supplying critical molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear...
- This federal contract award, identified as W81K0024P0074, was made by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The $33,333.33 firm fixed-price purchase order contract is for the delivery of various radiopharmaceuticals, which are critical for nuclear medicine imaging procedures and diagnostic services provided to veterans and military personnel at VA medical centers and military treatment facilities. RLS (USA) Inc. is a small...
- This is a federal contract award to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of radiopharmaceuticals and related supplies, with a ceiling value of $179,605.38 and a performance period through March 31, 2026. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and...
- This is a $425,725.07 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the supply of non-pet radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. It has a performance period from April 1, 2025 to March 31, 2026. The contract is not a set-aside. RLS (USA) Inc. is a small business that specializes in providing...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to RLS (USA) Inc., a small business radiopharmacy company. The contract has a ceiling value of $159,704.34 and will run until February 28, 2026. RLS (USA) Inc. will provide radiopharmaceuticals, including specific isotopes such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and gallium-68 dotatate (NETSPOT), to...
- This firm-fixed price federal contract award, valued at $425,794.77, was issued by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine diagnostic procedures at VA medical centers and military treatment facilities over a 6-month period ending in July 2024. RLS (USA) Inc. operates a nationwide network of 31 radiopharmacy facilities,...
- This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is a delivery order with a firm fixed price of $22,914.60 and a period of performance ending on December 31, 2024. The contract is for the delivery of the radiopharmaceutical product NETSPOT GA-68 to the Department of Veterans Affairs (VA), specifically the VA Integrated Service Network 2 (VISN 2). RLS (USA) Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 21 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $378,281.55, is for the delivery of radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and the Defense Health Agency...
- This contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of NETSPOT GA-68 radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $2,291.46 firm-fixed price contract has an ultimate completion date of August 21, 2024. RLS (USA) Inc. holds several federal contract Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency to facilitate the efficient procurement of its radiopharmaceutical products, including...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 on January 1, 2026, for the supply of radiopharmaceuticals for nuclear medicine patients. The contract carries a firm fixed-price ceiling value of $493,958.37 with an ultimate completion date of December 31, 2026, and will be performed in Lake Mary, Florida. This delivery order is not designated as a set-aside contract and...
- HT940622D0002Indefinite Delivery Contract
- HT940622D0002-HT941023F0004Delivery Order
This federal contract award is for the delivery of radiopharmaceuticals to the Defense Health Agency (DHA) and the Department of Veterans Affairs (VA). The prime contractor is RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company that specializes in providing radiopharmaceuticals and related services to the U.S. federal government. The contract has a ceiling value of $299,975.67 and a completion date of September 30, 2023. It is a delivery order contract with a firm-fixed price pricing type. RLS (USA) Inc. holds several federal contract Indefinite Delivery Vehicles (IDVs) with the VA and DHA, including a $4,998,603.38 contract with VA VISN 17 for radiopharmaceuticals, a $538,493.10 small business set-aside contract with VA VISN 2 for Netspot (Gallium-68 dotatate), and a $1,914,116.40 contract with the DHA for general radiopharmaceuticals. These IDVs enable RLS (USA) Inc. to provide consistent, on-demand radiopharmaceutical supplies to support federal healthcare facilities' nuclear medicine programs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Radiopharmaceuticals-NMCSD | N6264521R0050 | Department of the Navy Naval Supply Systems Command | Solicitation 2/2 | 9/29/21, 10:34 AM | |
Radiopharmaceuticals-NMCSD | Radiopharmaceuticals-NMCSD | Department of the Navy Naval Supply Systems Command | Pre-Solicitation 1/2 | 9/9/21, 1:50 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 8/7/23 | |
| P00001 | Other Administrative Action | $0 | 2/14/23 | |
| Not listed | Not listed | $300.0k | 11/10/22 |